Clinical Trial Update: The Efficacy and Safety of Combined Teriflunomide and High-dose Dexamethasone in Newly Diagnosed Primary Immune Thrombocytopenia (TEMPO-2) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial (TEMPO-2) is evaluating the combination of teriflunomide and high-dose dexamethasone for newly diagnosed primary immune thrombocytopeni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• AUBAGIO (TERIFLUNOMIDE)
• Decadron (Dexamethasone)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Immune Thrombocytopenia (ITP) | Phase 2 | Status: RECRUITING